Results 51 to 60 of about 1,222,172 (308)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

FAKTOR-FAKTOR YANG MEMPENGARUHI UNDERPRICING PADA PENAWARAN UMUM PERDANA DI BURSA EFEK JAKARTA

open access: yesBenefit Jurnal Manajemen dan Bisnis, 2007
The study aimed to examine the influence of factors in finance (firm size, ROI, financial leverage, EPS, proceeds, and current ratio) and non-finance (firm’s age, auditor’s and underwriter’s reputations, and sort of industry) on underpricing.
Suyatmin Suyatmin, Sujadi Sujadi
doaj  

TIMING OF DIVIDEND INITIATIONS OF POLISH IPOs. DOES THE ORIGINAL SHAREHOLDERS STRUCTURE MATTER? [PDF]

open access: yesAnnals of the University of Oradea: Economic Science, 2018
This study provides empirical Polish-sample evidence for how pre-IPO ownership structure affects the subsequent decision on the first dividend pay-out for stock market investors over the period 2009–2016.
Aleksandra Pieloch-Babiarz   +1 more
doaj  

Operating performance of SMEs in Thailand after going public

open access: yesManagement şi Marketing, 2019
This study investigates the operating performance of small and medium enterprises (SMEs) in Thailand, in terms of efficiency and profitability, after issuing initial public offering (IPO) in comparison to their pre-IPO performance.
Laokulrach Marisa
doaj   +1 more source

The timing of initial public offerings – non-numerical model based on qualitative trends

open access: yesJournal of Business Economics and Management, 2018
The objective of this study is to develop a qualitative model supporting chief financial officers (CFOs) while considering the timing of initial public offerings (IPOs) under conditions of underdeveloped capital markets, where decision making is often ...
Tomáš Meluzín   +5 more
doaj   +1 more source

Initial Public Offerings and Underwriter Reputation [PDF]

open access: yesThe Journal of Finance, 1990
ABSTRACTThis paper examined the returns earned by subscribing to initial public offerings of equity (IPOs). Rock (1986) suggests that IPO returns are required by uninformed investors as compensation for the risk of trading against superior information. We show that IPOs with more informed investor capital require higher returns.
Carter, Richard B, Manaster, Steven
openaire   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

The initial public offering of high-technology firms: female executive managers and innovation [PDF]

open access: yes, 2013
This study addresses how gender diversity in management teams influences the success of the IPO of research-intensive firms, and how critical indicators of innovation capabilities for those types of firms can mediate the gender ...
Benavides-Velasco, Carlos Angel   +1 more
core  

Underpricing, underperformance and overreaction in initial public offerings : evidence from investor attention using online searches [PDF]

open access: yes, 2008
Online activity of Internet users has proven very useful in modeling various phenomena across a wide range of scientific disciplines. In our study, we focus on two stylized facts or puzzles surrounding the initial public offerings (IPOs) - the ...
Brocklehurst, P   +4 more
core   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy